Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 136

1.

Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.

Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, McLean HQ.

Lancet Infect Dis. 2016 Apr 6. pii: S1473-3099(16)00129-8. doi: 10.1016/S1473-3099(16)00129-8. [Epub ahead of print]

PMID:
27061888
2.

Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons.

Li R, Stewart B, McNeil MM, Duffy J, Nelson J, Kawai AT, Baxter R, Belongia EA, Weintraub E.

Pharmacoepidemiol Drug Saf. 2016 Apr 1. doi: 10.1002/pds.3996. [Epub ahead of print]

PMID:
27037540
3.

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

Gaglani M, Pruszynski J, Murthy K, Clipper L, Robertson A, Reis M, Chung JR, Piedra PA, Avadhanula V, Nowalk MP, Zimmerman RK, Jackson ML, Jackson LA, Petrie JG, Ohmit SE, Monto AS, McLean HQ, Belongia EA, Fry AM, Flannery B.

J Infect Dis. 2016 May 15;213(10):1546-56. doi: 10.1093/infdis/jiv577. Epub 2016 Jan 6.

PMID:
26743842
4.

Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.

Dinis JM, Florek NW, Fatola OO, Moncla LH, Mutschler JP, Charlier OK, Meece JK, Belongia EA, Friedrich TC.

J Virol. 2016 Jan 6;90(7):3355-65. doi: 10.1128/JVI.03248-15.

PMID:
26739054
5.

Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.

Chung JR, Flannery B, Thompson MG, Gaglani M, Jackson ML, Monto AS, Nowalk MP, Talbot HK, Treanor JJ, Belongia EA, Murthy K, Jackson LA, Petrie JG, Zimmerman RK, Griffin MR, McLean HQ, Fry AM.

Pediatrics. 2016 Feb;137(2):1-10. doi: 10.1542/peds.2015-3279. Epub 2016 Jan 5.

PMID:
26738884
6.

Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses.

Thompson MG, Clippard J, Petrie JG, Jackson ML, McLean HQ, Gaglani M, Reis EC, Flannery B, Monto AS, Jackson L, Belongia EA, Murthy K, Zimmerman RK, Thaker S, Fry AM.

Pediatr Infect Dis J. 2016 Mar;35(3):299-308. doi: 10.1097/INF.0000000000001006.

PMID:
26658375
7.

Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.

Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi D, Kulkarni A, Audet S, Mercader S, McGrew M, Hickman CJ, Bellini WJ, Shivakoti R, Griffin DE, Beeler J.

J Infect Dis. 2016 Apr 1;213(7):1115-23. doi: 10.1093/infdis/jiv555. Epub 2015 Nov 23.

PMID:
26597262
8.

Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States.

Caspard H, Gaglani M, Clipper L, Belongia EA, McLean HQ, Griffin MR, Talbot HK, Poehling KA, Peters TR, Veney N, Ambrose CS.

Vaccine. 2016 Jan 2;34(1):77-82. doi: 10.1016/j.vaccine.2015.11.010. Epub 2015 Nov 14.

PMID:
26589519
9.

Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses.

Reber AJ, Kim JH, Biber R, Talbot HK, Coleman LA, Chirkova T, Gross FL, Steward-Clark E, Cao W, Jefferson S, Veguilla V, Gillis E, Meece J, Bai Y, Tatum H, Hancock K, Stevens J, Spencer S, Chen J, Gargiullo P, Braun E, Griffin MR, Sundaram M, Belongia EA, Shay DK, Katz JM, Sambhara S.

Open Forum Infect Dis. 2015 Apr 15;2(2):ofv052. doi: 10.1093/ofid/ofv052. eCollection 2015 Apr.

10.

Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes.

Spencer S, Chung J, Thompson M, Piedra PA, Jewell A, Avadhanula V, Mei M, Jackson ML, Meece J, Sundaram M, Belongia EA, Cross R, Johnson E, Bullotta A, Rinaldo C, Gaglani M, Murthy K, Clipper L, Berman L, Flannery B.

J Med Virol. 2016 Apr;88(4):719-23. doi: 10.1002/jmv.24373. Epub 2015 Sep 21.

PMID:
26334765
11.

Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial.

McLean HQ, Belongia EA, Kieke BA, Meece JK, Fry AM.

Open Forum Infect Dis. 2015 Jul 8;2(3):ofv100. doi: 10.1093/ofid/ofv100. eCollection 2015 Sep.

12.

Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults.

Talbot HK, Coleman LA, Zhu Y, Spencer S, Thompson M, Cheng PY, Sundaram ME, Belongia EA, Griffin MR.

BMC Infect Dis. 2015 Apr 23;15:195. doi: 10.1186/s12879-015-0926-8.

13.

Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine.

Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi D, Zhang C, Ngo L, Rubin S.

Open Forum Infect Dis. 2014 Oct 18;1(3):ofu094. doi: 10.1093/ofid/ofu094. eCollection 2014 Dec.

14.

Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season.

Havers F, Flannery B, Clippard JR, Gaglani M, Zimmerman RK, Jackson LA, Petrie JG, McLean HQ, Nowalk MP, Jackson ML, Monto AS, Belongia EA, Eng HF, Lamerato L, Campbell AP, Fry AM.

Clin Infect Dis. 2015 Jun 1;60(11):1677-80. doi: 10.1093/cid/civ146. Epub 2015 Feb 25.

PMID:
25722198
15.

Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.

Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, McLean HQ, Belongia EA, Gaglani M, Berman L, Foust A, Sessions W, Thaker SN, Spencer S, Fry AM; Centers for Disease Control and Prevention.

MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):10-5.

16.

Safety of measles-containing vaccines in 1-year-old children.

Klein NP, Lewis E, Fireman B, Hambidge SJ, Naleway A, Nelson JC, Belongia EA, Yih WK, Nordin JD, Hechter RC, Weintraub E, Baxter R.

Pediatrics. 2015 Feb;135(2):e321-9. doi: 10.1542/peds.2014-1822. Epub 2015 Jan 5.

17.

Using winter 2009-2010 to assess the accuracy of methods which estimate influenza-related morbidity and mortality.

Jackson ML, Peterson D, Nelson JC, Greene SK, Jacobsen SJ, Belongia EA, Baxter R, Jackson LA.

Epidemiol Infect. 2015 Aug;143(11):2399-407. doi: 10.1017/S0950268814003276. Epub 2014 Dec 12.

PMID:
25496703
18.

Validation of Health Event Capture in the Marshfield Epidemiologic Study Area.

Kieke AL, Kieke BA Jr, Kopitzke SL, McClure DL, Belongia EA, VanWormer JJ, Greenlee RT.

Clin Med Res. 2015 Dec;13(3-4):103-11. doi: 10.3121/cmr.2014.1246. Epub 2014 Dec 8.

19.

Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006.

Abrams JY, Weintraub ES, Baggs JM, McCarthy NL, Schonberger LB, Lee GM, Klein NP, Belongia EA, Jackson ML, Naleway AL, Nordin JD, Hambidge SJ, Belay ED.

Vaccine. 2015 Jan 3;33(2):382-7. doi: 10.1016/j.vaccine.2014.10.044. Epub 2014 Nov 4.

PMID:
25444786
20.

Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type.

McLean HQ, Thompson MG, Sundaram ME, Kieke BA, Gaglani M, Murthy K, Piedra PA, Zimmerman RK, Nowalk MP, Raviotta JM, Jackson ML, Jackson L, Ohmit SE, Petrie JG, Monto AS, Meece JK, Thaker SN, Clippard JR, Spencer SM, Fry AM, Belongia EA.

J Infect Dis. 2015 May 15;211(10):1529-40. doi: 10.1093/infdis/jiu647. Epub 2014 Nov 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk